• Accueil >
  • Publications >
  • High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma

1 mars 2020EBioMedicine

DOI : 10.1016/j.ebiom.2020.102702

Auteurs

Caroline Louis-Brennetot, Olivier Delattre, Isabelle Janoueix-Lerosey